Serena Kimi Perna

Title: Serena Kimi Perna: Innovator in Cancer Therapy

Introduction

Serena Kimi Perna is a notable inventor based in Philadelphia, PA (US). She has made significant contributions to the field of cancer therapy, particularly in the treatment of pancreatic cancer. Her innovative approach combines specific antibody therapies to enhance treatment efficacy.

Latest Patents

Serena holds a patent for a groundbreaking invention titled "Combination anti-CSF1R and anti-PD-1 antibody combination therapy for pancreatic cancer." This patent outlines methods for treating pancreatic cancer using particular dosage regimes of antibodies that bind to colony stimulating factor 1 receptor (CSF1R) and programmed cell death 1 (PD-1). She has 1 patent to her name, showcasing her commitment to advancing medical science.

Career Highlights

Throughout her career, Serena has worked with prominent companies in the biotechnology sector. She has been associated with Five Prime Therapeutics, Inc. and Bristol-Myers Squibb Company, where she has contributed to various research initiatives aimed at improving cancer treatments.

Collaborations

Serena has collaborated with esteemed colleagues, including Katherine E. Lewis and Michael Carleton. These partnerships have played a crucial role in her research and development efforts.

Conclusion

Serena Kimi Perna is a pioneering inventor whose work in cancer therapy is making a significant impact. Her innovative approaches and collaborations continue to push the boundaries of medical research and treatment options for pancreatic cancer.